Acton firm developing COVID-19 severity test
By Sam Bonacci Acton-based Bluejay Diagnostics, Inc. has partnered with Tokyo-based Toray Industries to develop a minimally-invasive, point-of-care test for COVID-19 patients to assess progression of the disease. The test, Symphony IL-6, measures the quantity of white blood cell protein in whole blood. It can be used with COVID-19 patients who present progressing symptoms as an aid in predicting the patients risk for intubation, according to a release from Bluejay, which manufactures and markets innovative clinical diagnostic products.. “Through our collaboration with Toray, w...
Source: wbjournal.com